Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.

Moxalactam (LY127935) exhibited greater in vitro activity than cefamandole and tobramycin against clinical isolates of Enterobacteriaceae, Aeromonas hydrophila, and Pseudomonas maltophilia. The activities of the three drugs against other microorganisms were as follows: for staphylococci, cefamandole...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Jones, R N, Fuchs, P C, Sommers, H M, Gavan, T L, Barry, A L, Gerlach, E H
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1980
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283866/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6446880/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.17.4.750
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!